Genetically Adjusted PSA May Improve Prostate Cancer Screening - Medscape
4/14/2022 12:00:00 AM3 yearsago
by Neil Osterweil
by Neil Osterweil
A validated genetic score can adjust PSA values to reduce overdiagnosis of prostate cancer and help distinguish clinically significant disease from indolent cancer.
NEW ORLEANS, Louisiana Prostate-specific antigen (PSA) is an imperfect screening biomarker for prostate cancer, but new data indicate that accounting for noncancer genetic factors that influence PSA … [+5751 chars]
full article...